Works matching IS 01145916 AND DT 2023 AND VI 46 AND IP 10

Results: 9

Real-World Safety and Efficacy of Biosimilar CT-P13 in Patients with Immune-Mediated Inflammatory Diseases: Integrated Analysis of Three Japanese Prospective Observational Studies.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 991, doi. 10.1007/s40264-023-01340-1

By:

Takeuchi, Tsutomu;
Nishikawa, Kiyohiro;
Yamada, Fumika;
Morita, Akimichi;
Ohtsuki, Mamitaro;
Suzuki, Yasuo;
Watanabe, Mamoru;
Yamanaka, Hisashi;
Hibi, Toshifumi

Publication type:

Article

Challenges and Opportunities in Accessing and Analysing FAERS Data: A Call Towards a Collaborative Approach.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 921, doi. 10.1007/s40264-023-01345-w

By:

Giunchi, Valentina;
Fusaroli, Michele;
Hauben, Manfred;
Raschi, Emanuel;
Poluzzi, Elisabetta

Publication type:

Article

Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient's Perspective.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 1039, doi. 10.1007/s40264-023-01343-y

By:

van Lint, Jette A.;
Sonnenberg, Marlieke;
Vonkeman, Harald E.;
van den Bemt, Bart J. F.;
van Puijenbroek, Eugene P.;
Jessurun, Naomi T.

Publication type:

Article

A Multi-method Exploratory Evaluation of a Service Designed to Improve Medication Safety for Patients with Monitored Dosage Systems Following Hospital Discharge.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 1021, doi. 10.1007/s40264-023-01342-z

By:

Alqenae, Fatema A.;
Steinke, Douglas;
Belither, Hilary;
Robertson, Peter;
Bartlett, Jennifer;
Wilkinson, Jack;
Williams, Steven D.;
Brad, Lawrence;
Jeffries, Mark;
Ashcroft, Darren M.;
Keers, Richard N.

Publication type:

Article

Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 1007, doi. 10.1007/s40264-023-01341-0

By:

Essink, Sharon C. M.;
Zomerdijk, Inge M.;
Straus, Sabine M. J. M.;
Gardarsdottir, Helga;
De Bruin, Marie L.

Publication type:

Article

Automated Classification of Quality Defect Issues Relating to Substandard Medicines Using a Hybrid Machine Learning and Rule-Based Approach.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 975, doi. 10.1007/s40264-023-01339-8

By:

Teo, Desmond Chun Hwee;
Huang, Yiting;
Dorajoo, Sreemanee Raaj;
Ng, Michelle Sau Yuen;
Choong, Chih Tzer;
Phuah, Doris Sock Tin;
Tan, Dorothy Hooi Myn;
Tan, Filina Meixuan;
Huang, Huilin;
Tan, Maggie Siok Hwee;
Koh, Suan Tian;
Poh, Jalene Wang Woon;
Ang, Pei San

Publication type:

Article

Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 961, doi. 10.1007/s40264-023-01338-9

By:

Khaemba, Christabel;
Barry, Abbie;
Omondi, Wyckliff P.;
Kirui, Elvis;
Oluka, Margaret;
Parthasarathi, Gurumurthy;
Njenga, Sammy M.;
Guantai, Anastacia;
Aklillu, Eleni

Publication type:

Article

Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 951, doi. 10.1007/s40264-023-01337-w

By:

Cho, Eun-Yeong;
Cho, Jung-Eun;
Jang, Seung Hun;
Hwang, Ki-Eun

Publication type:

Article

Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel.

Published in:

Drug Safety, 2023, v. 46, n. 10, p. 927, doi. 10.1007/s40264-023-01328-x

By:

Chiu, Joanne Wing Yan;
Lee, Soo Chin;
Ho, James Chung-man;
Park, Yeon Hee;
Chao, Ta-Chung;
Kim, Sung-Bae;
Lim, Elgene;
Lin, Ching-Hung;
Loi, Sherene;
Low, Su Ying;
Teo, Lynette Li San;
Yeo, Winnie;
Dent, Rebecca

Publication type:

Article